Pfizer has resolved a lawsuit by a conservative group that alleged that a fellowship program that the drugmaker established ...

Shares of Pfizer Inc. PFE shed 1.45% to $26.52 Friday, on what proved to be an all-around grim trading session for the stock ...

Pfizer Inc. and a conservative group agreed to end litigation challenging the legality of the company’s multi-year ...

The work underway at the former Pfizer headquarters marks a significant addition to Gensler’s office-to-residential ...

The company's revenue from operations dipped 0.4% to ₹538 crore as against ₹540 crore in the corresponding period of the preceding fiscal. At the operating level, EBITDA fell ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

Pfizer has resolved a lawsuit with a conservative group challenging its fellowship program aimed at increasing diversity, ...

The contrarian in me says that when everybody’s bullish about everything, it’s time to get a little cautious,’ says John ...

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...